A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gregory M Sullivan, MD
Tonix Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ashild Peters
Phoenix, Arizona, United States
- Ashild Peters
Little Rock, Arkansas, United States
- Ashild Peters
Rogers, Arkansas, United States
- Ashild Peters
Beverly Hills, California, United States
- Ashild Peters
Oceanside, California, United States
- Ashild Peters
Orange, California, United States
- Ashild Peters
Panorama City, California, United States
- Ashild Peters
Riverside, California, United States
- Ashild Peters
San Diego, California, United States
- Ashild Peters
Temecula, California, United States
- Ashild Peters
Colorado Springs, Colorado, United States
- Ashild Peters
Norwich, Connecticut, United States
- Ashild Peters
Washington D.C., District of Columbia, United States
- Ashild Peters
Jacksonville, Florida, United States
- Ashild Peters
North Miami, Florida, United States
- Ashild Peters
Orlando, Florida, United States
- Ashild Peters
Tampa, Florida, United States
- Ashild Peters
Alpharetta, Georgia, United States
- Ashild Peters
Lincolnwood, Illinois, United States
- Ashild Peters
Boston, Massachusetts, United States
- Ashild Peters
New Bedford, Massachusetts, United States
- Ashild Peters
Flowood, Mississippi, United States
- Ashild Peters
St Louis, Missouri, United States
- Ashild Peters
Las Vegas, Nevada, United States
- Ashild Peters
Oklahoma City, Oklahoma, United States
- Ashild Peters
Portland, Oregon, United States
- Ashild Peters
Salem, Oregon, United States
- Ashild Peters
Memphis, Tennessee, United States
- Ashild Peters
Austin, Texas, United States
- Ashild Peters
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Mar 2019
- Primary completion
- 24 Apr 2020
- Completion
- 24 Apr 2020
- Last update posted
- 6 Feb 2025
- Registered enrollment
- 192
- Registry id
- NCT03841773
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.